SCHEMBL614782

SCHEMBL614782

COc1ccc2[nH]c3c(C)c4ccn(C)c(=O)c4c(C)c3c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
MAPT P10636 3/20 0.53
RECQL P46063 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
POLB P06746 2/20 0.53
RAB9A P51151 2/20 0.53
TLR3 O15455 1/20 0.53
NR3C1 P04150 1/20 0.53
KIT P10721 1/20 0.53
PKM P14618 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TDP1 Q9NUW8 1/20 0.52
CDK4 P11802 2/20 0.50
CCND1 P24385 2/20 0.50
PDGFRB P09619 1/20 0.50
ALDH1A1 P00352 5/20 0.49
GAA P10253 3/20 0.49
HPGD P15428 3/20 0.49
DYRK1A Q13627 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614204 0.83 KIT (0.51) KITCDK4CCND1HPGDDYRK1A
SCHEMBL613137 0.78 LIMK1 (0.68) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL613967 0.75 KDM4E (0.63) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL9736132 0.73 KDM4E (0.65) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL9622716 0.73 PDGFRB (0.58) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL2311502 0.72 KDM4E (0.63) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL9622950 0.71 KDM4E (0.55) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL24782956 0.71 KDM4E (0.61) KDM4EMAPTRECQLMEN1KMT2A
SCHEMBL2546973 0.70 ALDH1A1 (0.56) KDM4EMAPTMEN1KMT2APOLB
SCHEMBL8128221 0.70 PDGFRB (0.70) KDM4EMAPTRECQLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604048-B2 Pyridocarbazole type compounds and applications thereof CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-12-10 US disclosed
US-20120041017-A1 PYRIDOCARBAZOLE TYPE COMPOUNDS AND APPLICATIONS THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041017-A1 PYRIDOCARBAZOLE TYPE COMPOUNDS AND APPLICATIONS THEREOF NLN, OPA1, PYCR1 KDM4E 3884/4885MAPT 10/4885RECQL 937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.